How much does Teleta Pharma Limited make?

Teleta Pharma Limited reported revenue of £13.3m and £730k profit in the year to 30 Jun 2025, according to its accounts filed at Companies House.

How many employees does Teleta Pharma Limited have?

Teleta Pharma Limited reported an average of 39 employees in the year to 30 Jun 2025.

Is Teleta Pharma Limited profitable?

Yes — Teleta Pharma Limited reported a profit of £730k in the year to 30 Jun 2025.

Company No. 06800217 · Incorporated 23 Jan 2009

Teleta Pharma Limited

Registered name: TELETA PHARMA LIMITED

Part of Teleta Pharma Holdings Limited group

Teleta Pharma Limited made £13.3m revenue and £730k profit in the year to 30 Jun 2025.

Teleta Pharma Limited’s revenue fell 5% to £13.3m in the year to 30 Jun 2025, with £730k profit and 39 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Loughton; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Loughton, London
Age: 17 yrs · since 2009
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 30 Jun 2025

Key figures

Capital-light

Revenue

£13.3m

Growth ▼4.7%

Profit

£730k

Growth ▲14.4%

Profit margin

5.5%

Gross 20.8%

Employees

Change ▼2.5%

Profit / employee

£18.7k

Revenue/employee £342k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Jun 2022	30 Jun 2023	30 Jun 2024	30 Jun 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£15.2m	£16.5m	£14m	£13.3m
Cost of sales	£12.6m	£13.6m	£11.4m	£10.6m
Gross profit	£2.6m	£2.9m	£2.6m	£2.8m
Operating profit	£765k	£904k	£667k	£766k
Profit before tax	£762k	£904k	£757k	£878k
Profit after tax	£648k	£751k	£638k	£730k
Profit (best available)	£648k	£751k	£638k	£730k
Staff costs	£1.2m	£1.3m	£1.3m	£1.3m
Employees (average)	40	42	40	39
Ratios
Profit margin	4.3%	4.6%	4.6%	5.5%
Gross margin	17.3%	17.4%	18.3%	20.8%
Revenue per employee	£381k	£392k	£350k	£342k
Profit per employee	£16.2k	£17.9k	£16k	£18.7k
Growth (year on year)
Revenue growth	—	▲8%	▼14.9%	▼4.7%
Profit growth	—	▲16%	▼15.1%	▲14.4%
Headcount growth	—	▲5%	▼4.8%	▼2.5%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.5m	£1.9m	£641k	£476k
Net assets	£2.5m	£3.3m	£3.9m	£4.6m
Fixed assets	£205k	£166k	£131k	£170k
Current assets	£8.6m	£9.4m	£9.8m	£9.5m
Debtors	£1.9m	£1.7m	£1.1m	£1.4m
Deferred income	£42.1k	£68k	£97.2k	£87.4k
Source	Accounts · bulk data May 2024	Accounts · bulk data May 2024	FullAccounts · bulk data Mar 2025	FullAccounts · bulk data Mar 2026

Derived from the latest filing

How the business works

Profit margin: 5.5%; Profit ÷ revenue.
Gross margin: 20.8%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £342k; Revenue ÷ average employees.
Profit per employee: £18.7k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 1.3%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 0.7%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 10.2%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲19%; Now £4.6m
Cash at bank: ▼26%; Now £476k
Headcount: ▼3%; Now 39
Deferred income: ▼10%; Now £87.4k
Fixed assets: ▲29%; Now £170k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Teleta Pharma Holdings Limitedultimate parent75–100%
Teleta Pharma Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (1)

BR Pharma International LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Jun 2025 (profit £730k), from the Companies House accounts bulk data published Mar 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.